Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]
Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has complete…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of Modakafusp Alfa (TAK-573) alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the trial wa…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Dendritic Cell Vaccination in Patients With Advanced Melanoma [Phase 1]
Phase 1 clinical trial evaluating dendritic cell vaccination in patients with advanced melanoma; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 study assessing safety, tolerability, and preliminary efficacy of CJRB-101 in combination with pembrolizumab in selected advanced …
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: A Study of IBI363 in Subjects with Advanced Solid Malignancies [Phase 2]
Phase 2 study of IBI363 in advanced solid malignancies is currently recruiting, with indications including melanoma, non-small cell lung can…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Rural Adult and Youth Sun Protection Study [NA]
A clinical trial update for the Rural Adult and Youth Sun Protection Study, sponsored by the University of Utah, currently recruiting for me…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT [Phase 1, Phase 2]
Update on a Phase I/IIa PET imaging trial of 68GaNOTA-Anti-MMR-VHH2 for malignant solid tumors, including breast cancer and melanoma; the st…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma [Phase 1, Phase 2]
Zhuhai Yufan Biotechnologies Co., Ltd. is conducting a Phase Ib/Phase II trial of PRJ1-3024 for advanced or metastatic melanoma. The study i…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma [Phase 1]
A phase 1 trial evaluating the combination of ipilimumab and nivolumab for stage III/IV unresectable/metastatic cutaneous melanoma has been …
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study of Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating the combination of TBI-1401(HF10) and ipilimumab in Japanese patients with unresectable or metastatic melanoma ha…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Family History App in Personalized Medicine [NA]
An update on a university-sponsored clinical trial evaluating a family history app for personalized medicine; the study is currently active …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
An update on an ongoing trial at Aarhus University Hospital evaluating cognitive function in melanoma patients treated with adjuvant immune …
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating IOV-4001 for unresectable or metastatic melanoma and stage III/IV non-small cell lung cancer is currently recruit…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
A clinical trial is evaluating the PET imaging tracer 68Ga-DOTA-Siglec-9 in cancer patients. The study is currently enrolling by invitation …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
An Ontario-wide clinical trial evaluating targeted nucleic acid analysis for cancer is currently recruiting across multiple cancer types, pe…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Dietary Intervention in Patients with a History of Melanoma [Phase 1]
A Phase 1 trial evaluating a dietary intervention in patients with a history of melanoma has been terminated; no results are reported in the…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: CD8 Minibody Repeatability Study [Phase 2]
ImaginAb's Phase 2 CD8 minibody repeatability study in melanoma and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Phase IIB TL + YCWP + DC in Melanoma [Phase 2]
A Phase II trial evaluating TL + YCWP + DC in melanoma has completed, and results have been posted.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma
Clinical trial update describing a study using liquid biopsy tracking in immunotherapy-treated stage IV melanoma; the trial is not yet recru…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma [Phase 2]
Phase 2 trial evaluating the combination of nivolumab, ipilimumab, and cabozantinib in patients with unresectable advanced melanoma; results…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Radiotherapy & Combi in Metastatic Melanoma [Phase 1, Phase 2]
The study evaluating radiotherapy in combination with other therapies for metastatic melanoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Neurotropic Melanoma of the Head and Neck [NA]
A clinical trial update notes completion of a study on neurotropic melanoma of the head and neck.
-
CLINICAL_TRIALS other · 2024-11-27Clinical Trial Update: MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma [NA]
This clinical trial compares 1 cm versus 2 cm wide excision margins for primary cutaneous melanoma and is currently active but not recruitin…